Esophageal Diseases Clinical Trial
Official title:
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
Cellspan™ Esophageal Implant-Adult (CEI) The CEI is a combination product consisting of an engineered synthetic scaffold (device constituent) seeded and cultured with the patient's adipose derived mesenchymal stem cells (biologic constituent), intended to stimulate regeneration of a structurally intact, living biologic esophageal conduit, in patients requiring full circumferential esophageal reconstruction up to 6 cm segment in length. This is a single arm, unblinded, multicenter, prospective first-in-human (FIH) feasibility study to be performed at a maximum of 5 centers in the United States with a maximum of 10 subjects in total. All subjects will be followed for a minimum of 2 years post-implant surgery. Since this is an FIH experience, the study will utilize an independent Data Monitoring Committee (DMC) to evaluate safety on a continuous basis to mitigate any safety risks to subjects. A sentinel approach to enrollment of subjects shall be guided by the DMC review of cases.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05054933 -
Ultrasound Capsule Endoscopy for Esophagus Examination
|
N/A | |
| Completed |
NCT04090554 -
Cytosponge™ Feasibility Study in Tanzania
|
N/A | |
| Active, not recruiting |
NCT03962179 -
Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)
|
N/A | |
| Completed |
NCT03549494 -
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
|
Phase 2 | |
| Recruiting |
NCT04481100 -
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
|
Phase 2 | |
| Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
| Completed |
NCT00977678 -
Drop in Gastroscopy - Experience After 9 Months
|
N/A | |
| Recruiting |
NCT04068480 -
Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy
|
||
| Completed |
NCT00874263 -
Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies
|
N/A | |
| Terminated |
NCT00442507 -
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
|
Phase 2 | |
| Recruiting |
NCT03832959 -
Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.
|
N/A | |
| Withdrawn |
NCT02569073 -
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
|
Phase 4 | |
| Recruiting |
NCT05252078 -
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
|
Phase 2 | |
| Recruiting |
NCT00260585 -
Esophageal Cancer Risk Registry
|
||
| Completed |
NCT03187314 -
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
|
Phase 2 | |
| Recruiting |
NCT05004155 -
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
|
||
| Recruiting |
NCT05469152 -
Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases
|
N/A | |
| Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
| Recruiting |
NCT05311787 -
The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery
|
N/A | |
| Recruiting |
NCT00939263 -
Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
|
N/A |